# Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

> **NCT07285668** · NA · SUSPENDED · sponsor: **University of Wisconsin, Madison** · enrollment: 38 (estimated)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **DEVICE:** Allogeneic donor TCRαβ+/CD19+ cell-depleted peripheral blood mononuclear cells

## Key facts

- **NCT ID:** NCT07285668
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2026-02-26
- **Primary completion:** 2029-02
- **Final completion:** 2031-02
- **Target enrollment:** 38 (ESTIMATED)
- **Why stopped:** Protocol Modifications
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07285668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07285668, "Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07285668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*